WEST LAFAYETTE, Ind., Nov. 26, 2013 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT), a biopharmaceutical company and leader in developing targeted small molecule drug conjugates (SMDCs) and companion imaging agents for personalized therapy in cancer and other serious diseases, today announced that Ron Ellis, Endocyte's president and CEO, will present at the Piper Jaffray 25th Annual Health Care Conference on Tuesday, Dec. 3, at 9 a.m. EST. The conference is being held at The New York Palace Hotel in New York.
Help employers find you! Check out all the jobs and post your resume.
